Recovery of Motor Skills With the Use of Artificial Intelligence and Computer Vision

Recovery of Motor Functions Through Assistive Motion Capture Software Using Artificial Intelligence and Computer Vision

To investigate the impact of algorithms utilizing artificial intelligence technology and computer vision on the recovery of motor functions within the context of rehabilitation practice for patients who have experienced a cerebral stroke.

Study Overview

Detailed Description

Progress in artificial intelligence (AI) technologies and their practical application across various fields, notably in medicine, showcases their potential in solutions such as automated diagnostic systems, unstructured medical record recognition, natural language understanding, event analysis and prediction, information classification, automatic patient support via chatbots, and movement analysis through video. Currently, diverse AI-based software systems are being developed, designed to solve intellectual problems akin to human thinking. AI's widespread applications encompass prediction, evaluation of digital information (including unstructured data), and pattern recognition (data mining).

Amid rapid advancements in deep machine learning, particularly in image and pattern recognition, medical image analysis has gained prominence within automated diagnostic systems, particularly in radiation diagnostics. With the burgeoning field's rapid growth, curating medical datasets for AI-based diagnostic system training and validation is crucial.

AI's success in radiation diagnostics and its recognition as promising within scientific circles pave the way for video analysis and machine learning's integration into medical rehabilitation practice. Collaborating, researchers at the Federal Medical Research Center of the FMBA of Russia and MTUCI devised a plan to develop specialized algorithms based on video movement analysis and machine learning for stroke patients undergoing medical rehabilitation.

These algorithms monitor patients' movements and promptly notify them of deviations, amplitude reductions, or compensatory patterns, aiding them in correcting their movements. All session data is archived electronically, accessible to medical professionals responsible for individualized lesson plans. This enables assessment of patient progress and necessary adjustments to the home rehabilitation program.

Incorporating AI-driven video analysis and machine learning into medical rehabilitation holds great potential for enhancing patient outcomes and personalizing treatment strategies.

Study Type

Interventional

Enrollment (Estimated)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

Recent hemispheric stroke (ischemic or hemorrhagic):

  • Rankin scale: 3
  • Within 6 months post stroke.
  • Upper limb hemiparesis with strength ≤3 points proximally.
  • Muscle tone rise (≤3 points) on Ashford scale.
  • Complex sensitivity preserved per neuro examination

Exclusion Criteria:

  • Rankin scale of 4 points and higher.
  • 6 months or more after undergoing stroke.
  • Structural changes in the joints of the upper extremities that limit joint mobility (contractures, ankylosis, metal structures that limit mobility).
  • Severe pain syndrome in the paretic upper limb at rest or when moving, preventing exercise (7 points or more on the scale).
  • Gross cognitive disorders, psychoemotional arousal, signs of hysteria, pseudobulbar syndrome (violent laughter, crying), aphasic disorders that prevent understanding of the task.
  • Visual disturbances that prevent the perception of information (neglect, hemianopia, myopia, diplopia).
  • Thrombosis of the veins in the upper and lower extremities without signs of recanalization, or arterial thrombosis.
  • Parkinsonism and other types of tremor.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: AssistI patients
Patients will receive rehabilitation training using the AsistI software package in conjunction with standard upper limb rehabilitation interventions.
The AsistI software package rehabilitation involves tailored upper limb exercises under an individual program. The regimen consists of 10-12 sessions, each lasting 30 minutes. Patients execute 10 exercises sequentially with their unaffected and affected limbs, involving tasks like touching mouth, forehead, and trunk parts with hand's brush, and amplitude movements in upper limb joints. AsistI assesses exercise accuracy, prevents unfavorable patterns, and logs target achievement, considering speed, accuracy, and repetitions.
Active Comparator: Habilect patients
Patients will receive rehabilitation training using the Habilect software and hardware complex, in addition to standard rehabilitation interventions for the upper limb.
The Habilect rehab program involves 10-12 sessions using software and hardware. Patients perform upper limb exercises for 30 minutes individually, focusing on specific movements. They repeat 10 exercises, first with the healthy limb, then the affected one. Tasks include touching mouth, forehead, and trunk, along with joint movements like shoulder flexion. Habilect assesses exercise accuracy, preventing wrong moves, and tracks progress, considering speed, accuracy, repetitions.
No Intervention: Conventional therapy patients
Patients will undergo standard upper limb rehabilitation interventions without the utilization of additional methods.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fugl-Meyer Assessment Scale for upper extremity assessment (FMA-UE)
Time Frame: Change from baseline at 3 weeks
In this study, we wiil use 36 items of the upper arm (proximal musculature, FMA-UA), 24 items of wrist and hand (distal musculature, FMA-W/H), 6 items of aspects of coordination, 12 items of aspects of sensation, 24 items of aspects of passive joint movement, 24 items of joint pain. So the maximum total score on this FMA-UE scale was 126 points.
Change from baseline at 3 weeks
Muscle strength was assessed using the MRC (Medical Research Council Weakness Scale)
Time Frame: Change from baseline at 3 weeks
MRC is a commonly used scale for assessing muscle strength from Grade 5 (normal) to Grade 0 (no visible contraction). Paresis is defined as light at compliance with strength 4 points, moderate - 3 points, pronounced - 2 points, rough - 1 point and with - 0 points.
Change from baseline at 3 weeks
The Action Research Arm Test (ARAT)
Time Frame: Change from baseline at 3 weeks
Is a 19 item observational measure used by physical therapists and other health care professionals to assess upper extremity performance (coordination, dexterity and functioning) in stroke recovery, brain injury and multiple sclerosis populations. Scores on the ARAT may range from 0-57 points, with a maximum score of 57 points indicating better performance. MCID has been suggested as 5.7 points
Change from baseline at 3 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The speed of movement of the upper limb
Time Frame: Change from baseline at 3 weeks
Upper limb movement speed: Time to reach the target (sec).
Change from baseline at 3 weeks
Accuracy of performed movements
Time Frame: Change from baseline at 3 weeks
Movement accuracy: Precision in touching guided points (angles).
Change from baseline at 3 weeks
Total number of repetitions
Time Frame: Change from baseline at 3 weeks
Repetition count: Number of motor attempts for the goal.
Change from baseline at 3 weeks
The correctness of the exercises
Time Frame: Change from baseline at 3 weeks
Exercise correctness: Number of compensatory actions like shoulder elevation or torso bend.
Change from baseline at 3 weeks
The number of exercises completed
Time Frame: Change from baseline at 3 weeks
Correct repetition count: Number of attempts without compensation, e.g., shoulder or torso movements.
Change from baseline at 3 weeks
The number of exercises not completed
Time Frame: Change from baseline at 3 weeks
Incorrect repetition count: Number of attempts with compensatory actions, e.g., shoulder lift or torso bend.
Change from baseline at 3 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Galina Ivanova, Prof, Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health
  • Study Chair: Michael Gorodnichev, Moscow Technical University of Communication and Informatics (MTUCI)

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

February 1, 2024

Primary Completion (Estimated)

August 1, 2024

Study Completion (Estimated)

February 1, 2025

Study Registration Dates

First Submitted

August 24, 2023

First Submitted That Met QC Criteria

December 26, 2023

First Posted (Actual)

December 28, 2023

Study Record Updates

Last Update Posted (Actual)

December 28, 2023

Last Update Submitted That Met QC Criteria

December 26, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on AssistI patients

Subscribe